U.S. Internet of Medical Things Market: $365.42B by 2035

Market Outlook

By 2035, the U.S. Internet of Medical Things Market is expected to reach approximately USD 365.42 billion, expanding at a CAGR of 16.60% during the forecast period 2026–2035. The market is estimated at USD 78.67 billion in 2025, with historical analysis covering 2021–2024. Values in this report are expressed in USD billions.

The historical market expanded from approximately USD 42.56 billion in 2021 to USD 49.63 billion in 2022, USD 57.86 billion in 2023, and USD 67.47 billion in 2024. The market is expected to advance to approximately USD 91.73 billion in 2026, marking the beginning of a decade in which connected medical devices transition from supplementary digital tools into core components of U.S. care delivery infrastructure.

The U.S. Internet of Medical Things, or IoMT, market encompasses connected medical devices, sensors, monitoring systems, device-management platforms, clinical software, connectivity infrastructure, and supporting services that securely collect, transmit, analyze, and operationalize medical information. The economic value of IoMT increasingly comes from the ability to connect devices to clinical decision-making rather than connectivity itself. Health systems are therefore evaluating IoMT platforms through outcomes such as reduced manual documentation, earlier identification of deterioration, improved asset utilization, lower avoidable admissions, greater clinician productivity, and the ability to extend care into the home.

Demand is reinforced by the extraordinary scale of the U.S. healthcare system. National health expenditures reached approximately USD 5.3 trillion in 2024, while hospital expenditures exceeded USD 1.63 trillion. The country also operates more than 6,000 hospitals, with approximately 907,000 staffed beds and more than 35 million hospital admissions annually. Each of these environments contains a growing base of network-addressable monitors, infusion systems, imaging equipment, mobile diagnostic devices, wearable sensors, smart beds, implantable devices, medication-management technologies, and home-monitoring endpoints.

Demographics add another structural growth layer. The U.S. population aged 65 and above reached approximately 61.2 million in 2024, representing about 18% of the population. Older patients disproportionately consume healthcare resources and are more likely to require monitoring for hypertension, diabetes, cardiovascular disease, respiratory disorders, sleep disorders, arrhythmias, and other chronic conditions. Connected care enables health systems to monitor these populations without requiring every clinical interaction to occur inside a hospital or physician office.

From 2026 through 2035, IoMT purchasing will increasingly move from isolated device deployment toward enterprise connected-care architecture. Hospitals will prioritize interoperability, cybersecurity, device identity, fleet management, automated data capture, cloud integration, edge computing, artificial intelligence, and standardized interfaces with electronic health records. Manufacturers capable of combining clinically validated hardware with secure software, recurring analytics, workflow integration, and post-market cybersecurity management will be positioned to capture a disproportionate share of market growth.

Introduction

According to the U.S. Internet of Medical Things Market Report, the United States represents one of the world’s most commercially advanced connected-health environments because it combines high healthcare expenditure, mature medical device adoption, extensive broadband and wireless infrastructure, sophisticated hospital IT systems, strong reimbursement economics, a large chronic disease population, and one of the deepest digital-health innovation ecosystems globally.

IoMT should not be viewed simply as medical devices connected to the internet. In the U.S. healthcare environment, the market is developing into a distributed clinical intelligence layer. A blood pressure monitor, CGM sensor, wearable ECG patch, pulse oximeter, smart infusion pump, connected ventilator, imaging system, implanted cardiac device, or hospital telemetry monitor creates greater value when its data can be automatically transmitted, prioritized, incorporated into the patient record, and acted upon by a clinical team.

The U.S. market is particularly attractive because connected medical technologies can address several of the most expensive structural problems in healthcare simultaneously. These include nursing workload, specialist shortages, chronic disease management, hospital readmissions, fragmented patient monitoring, inefficient equipment utilization, documentation burden, and care transitions between hospital, outpatient, post-acute, and home settings.

The economic argument for IoMT is becoming stronger as care delivery becomes more distributed. Hospitals remain the largest purchasing environment, but connected medical devices are increasingly deployed in physician practices, ambulatory facilities, skilled nursing settings, pharmacies, diagnostic centers, and patient homes. Medicare broadly covers qualifying remote patient monitoring for acute and chronic conditions when appropriate connected medical devices digitally collect and transmit physiologic information. This gives IoMT an important reimbursement-supported route into longitudinal disease management rather than limiting the market to hospital capital budgets.

A second defining characteristic is the increasing overlap between regulated medical devices and software infrastructure. The commercial performance of an IoMT device may depend as much on its cloud environment, interoperability, cybersecurity architecture, dashboard usability, analytics, and electronic health record integration as on sensor accuracy. Hospital procurement committees increasingly involve clinicians, biomedical engineering teams, chief information officers, cybersecurity specialists, supply-chain executives, finance teams, and value-analysis committees.

This makes the U.S. IoMT market fundamentally different from a conventional hardware market. Revenue increasingly extends beyond the initial device sale into software licenses, connectivity, analytics, device management, support, monitoring services, cloud hosting, cybersecurity maintenance, and replacement ecosystems. Vendors that establish large connected-device fleets can therefore create high customer switching costs and recurring revenue streams.

Key Market Drivers: What’s Fueling the U.S. Internet of Medical Things Market Boom?

One of the strongest market drivers is the increasing clinical and economic burden of chronic disease. Chronic diseases remain among the leading causes of illness, disability, mortality, and healthcare expenditure in the United States. Current public-health assessments indicate that approximately three in four U.S. adults have at least one chronic condition and more than half have multiple chronic conditions. These patients often require repetitive measurement of blood pressure, glucose, oxygen saturation, cardiac rhythm, respiratory status, weight, sleep characteristics, medication adherence, or other physiologic indicators.

IoMT enables these measurements to become continuous or longitudinal rather than episodic. For diabetes, connected glucose monitoring can provide a much richer clinical picture than occasional office measurements. In hypertension, digitally connected blood pressure monitoring allows clinicians to evaluate trends across weeks rather than relying on an isolated reading. Cardiology increasingly uses connected ECG patches, implanted monitors, pacemaker telemetry, and mobile cardiac telemetry. Respiratory care is incorporating connected pulse oximetry, PAP platforms, inhaler monitoring, and home respiratory technologies.

A second major driver is the scale of U.S. hospital digital transformation. Hospitals operate thousands of medical devices that traditionally functioned as separate equipment islands. Health systems are increasingly connecting those devices to clinical networks so that patient data can flow automatically into centralized monitoring systems and electronic records. Smart beds, patient monitors, infusion pumps, ventilators, mobile imaging systems, diagnostic equipment, telemetry platforms, and alarm-management systems are increasingly treated as part of a connected clinical architecture.

This transition has significant workflow economics. Manual device-data entry consumes nursing time and can create transcription risk. Connected infrastructure can automate selected documentation, improve device visibility, support predictive maintenance, streamline equipment allocation, and allow clinicians to monitor multiple patients remotely. For health systems dealing with labor shortages and rising wage costs, workforce productivity has become an important IoMT purchasing argument.

Remote patient monitoring is a third powerful growth engine. Medicare coverage provides an established framework for monitoring qualifying acute and chronic patients using internet-connected medical devices that meet regulatory requirements and digitally upload health information. Commercial payers and risk-bearing provider organizations are also increasingly interested in technologies that identify patient deterioration before it results in an emergency department visit or hospitalization.

Remote monitoring changes the economic unit of healthcare. Instead of generating value only during a procedure or inpatient episode, the connected medical device can remain clinically relevant for weeks, months, or years. This creates opportunities for recurring software, monitoring, and data-service revenue while giving providers an infrastructure for longitudinal care.

The aging U.S. population adds further momentum. Americans aged 65 and older reached approximately 61.2 million in 2024 and are growing substantially faster than younger population groups. This demographic shift supports demand for connected cardiovascular monitoring, diabetes technologies, home respiratory care, fall detection, sleep monitoring, post-surgical surveillance, medication management, and decentralized diagnostics.

A fifth driver is the increasing adoption of value-based care. Traditional fee-for-service healthcare rewards activity, but value-based arrangements increase the financial relevance of preventing avoidable hospitalization and managing high-risk populations. Connected devices can help provider organizations identify deterioration, prioritize outreach, improve adherence, and document patient trends. IoMT therefore becomes more strategically valuable when hospitals or physician groups accept financial responsibility for outcomes.

A sixth driver is artificial intelligence. Connected devices generate large volumes of physiological and operational data. AI can convert these streams into actionable information by identifying abnormal patterns, prioritizing alerts, supporting diagnostic interpretation, estimating deterioration risk, and reducing the number of data points that require manual review. FDA-authorized AI-enabled medical devices now span cardiovascular care, radiology, neurology, pathology, and other disciplines, creating a foundation for increasingly intelligent IoMT ecosystems.

Cybersecurity regulation is simultaneously creating both a requirement and a competitive advantage. Connected medical devices create potential attack surfaces, and U.S. regulatory expectations increasingly require manufacturers of qualifying cyber devices to address cybersecurity throughout the product lifecycle. Device manufacturers must consider vulnerability management, post-market patches, software bills of materials, secure architecture, and coordinated vulnerability disclosure. Large health systems increasingly treat cybersecurity readiness as a procurement threshold rather than an optional technical feature.

Finally, home-centered healthcare is expanding the addressable market. Medical technology historically followed the patient into the hospital. IoMT allows clinical capability to follow the patient home. This transition expands opportunities for medical device manufacturers while increasing the importance of usability, wireless reliability, battery performance, patient engagement, automated onboarding, and simplified remote support.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. IoMT market is moving from connectivity toward clinically intelligent connectivity. Simply transmitting device data is no longer sufficient differentiation. Manufacturers are competing on whether their platforms can identify meaningful changes, reduce unnecessary alerts, fit existing clinical workflows, integrate with enterprise IT architecture, and support measurable healthcare economics.

Artificial intelligence is becoming embedded across connected-device ecosystems. AI-assisted ECG interpretation, image analysis, remote monitoring prioritization, predictive deterioration algorithms, automated insulin delivery, clinical alarm management, and patient-risk stratification are converting raw sensor streams into higher-value clinical outputs. This creates opportunities for manufacturers to differentiate identical or similar hardware through software intelligence.

Wearable medical technology is also evolving rapidly. The category is moving beyond wellness tracking toward medically actionable monitoring. FDA-authorized sensor-based digital health technologies increasingly include patches, watches, bands, and other minimally invasive devices capable of collecting physiological data outside conventional clinical settings. Cardiovascular monitoring remains especially advanced, but neurological, metabolic, respiratory, sleep, and maternal-health applications are expanding.

Continuous glucose monitoring illustrates how connected medical devices can reshape an entire clinical workflow. CGM has shifted diabetes monitoring from intermittent measurement toward continuous trend analysis and has increasingly moved beyond intensively managed insulin-dependent patients. Broader accessibility, smartphone integration, automated insulin delivery, and over-the-counter pathways create a template for how other IoMT categories could evolve.

Hospital-device connectivity is another major innovation area. Vendors are building enterprise systems capable of discovering devices, monitoring connectivity status, tracking location, managing software versions, routing device data, and supporting cybersecurity governance across large fleets. This infrastructure is particularly important for integrated delivery networks operating dozens of hospitals and thousands of connected endpoints.

Edge computing is becoming strategically important because not every clinical decision should depend on a remote cloud environment. Processing selected information at or near the medical device can reduce latency, maintain functionality during network interruptions, improve privacy, and support high-frequency data analysis. Hybrid edge-cloud architectures are therefore likely to become increasingly important in critical care, imaging, surgical systems, and continuous monitoring.

Interoperability is also moving higher on hospital procurement agendas. Health systems increasingly expect connected medical devices to communicate with electronic health records and enterprise clinical systems without extensive custom integration. Standards-based architecture, APIs, automated patient-device association, and semantic consistency can materially reduce implementation complexity.

Cybersecurity engineering represents another important innovation cycle. FDA expectations for cyber devices are encouraging manufacturers to build cybersecurity into design controls rather than treating it as a post-development activity. Secure update mechanisms, authentication, encryption, access control, vulnerability monitoring, software-component transparency, and lifecycle patching will influence product competitiveness throughout the forecast period.

Manufacturers are also improving the patient-facing layer. Home IoMT devices must operate outside controlled hospital environments, often with elderly or medically complex users. Devices that require complex pairing, frequent charging, manual data uploads, or complicated troubleshooting may experience poor adherence regardless of clinical accuracy. Successful companies are therefore investing in cellular connectivity, automatic transmission, longer battery life, simplified interfaces, disposable sensors, remote technical support, and passive data collection.

The next stage of U.S. IoMT competition will increasingly center on closed-loop healthcare. Connected devices will not only observe patients; selected systems will detect a physiological change, interpret it, recommend an action, adjust therapy where authorized, document the intervention, and update the clinical team. Automated insulin delivery already demonstrates this model. Similar closed-loop architectures are likely to develop across respiratory care, medication delivery, critical-care monitoring, neuromodulation, and other therapeutic categories.

Segmentation Insights

The U.S. Internet of Medical Things Market is segmented on the basis of component, device type, application, end user, and region.

By Component

Hardware

Hardware represents the largest foundation of the IoMT value chain and accounted for an estimated 43% of U.S. market revenue in 2025, equivalent to approximately USD 33.82 billion. The category includes sensors, wearable devices, patient monitors, implanted connected devices, gateways, smart medical equipment, connectivity modules, diagnostic hardware, and other network-enabled medical technologies.

Hardware demand benefits from continuous replacement cycles and expansion of the installed connected-device base. However, competitive differentiation is increasingly dependent on the software and services surrounding the physical device. Manufacturers able to combine clinically validated sensing with reliable connectivity, low power consumption, cybersecurity, interoperability, and user-friendly design will gain stronger pricing power.

Software and IoMT Platforms

Software and platform technologies represented approximately 31% of the 2025 market, or around USD 24.39 billion. This segment encompasses device-management software, clinical dashboards, data-integration platforms, cloud applications, analytics, remote monitoring software, cybersecurity layers, patient applications, and AI-supported decision tools.

Software is expected to expand faster than the overall market because every additional connected endpoint creates requirements for device orchestration, data processing, security, visualization, and workflow management. Enterprise health systems increasingly prefer platforms capable of managing multiple device categories rather than isolated proprietary dashboards.

Services

Services represented approximately 26% of the U.S. IoMT market in 2025, equivalent to around USD 20.45 billion. Services include implementation, integration, managed connectivity, cloud hosting, monitoring support, cybersecurity services, equipment maintenance, training, clinical operations support, and analytics services.

This category is strategically important because IoMT deployments frequently require integration across biomedical engineering, IT, cybersecurity, nursing, and clinical operations. Large health systems increasingly evaluate total lifecycle cost, making implementation quality and ongoing support critical components of vendor selection.

By Device Type

On-Body and Wearable Medical Devices

On-body technologies are among the fastest-growing IoMT categories. These include continuous glucose monitors, ECG patches, wearable cardiac monitors, pulse oximeters, sleep sensors, connected blood-pressure technologies, medical-grade smartwatches, and other body-worn sensors.

Their commercial advantage comes from the ability to collect longitudinal information while patients continue normal daily activities. Wearable medical devices can expand diagnostic windows from minutes to days or weeks, increasing the probability of detecting intermittent events and providing clinicians with real-world physiological information.

Stationary Connected Medical Devices

Stationary devices include connected bedside monitors, infusion systems, ventilators, imaging equipment, dialysis systems, laboratory equipment, smart beds, and other hospital-based technologies. This segment remains a major value pool because high-acuity hospitals maintain extensive installed bases of networkable equipment.

Growth is shifting from simply connecting these devices toward centralized command centers, automated clinical documentation, device fleet management, predictive maintenance, alarm optimization, and cybersecurity oversight.

Implantable Connected Medical Devices

Implanted IoMT devices include connected pacemakers, defibrillators, implantable cardiac monitors, neuromodulation systems, implantable glucose-related technologies, and other devices capable of providing information or receiving programming after implantation.

These systems create particularly durable data relationships because the device may remain with a patient for years. Remote follow-up can reduce routine clinic visits, allow earlier detection of abnormalities, and increase manufacturer involvement throughout the product lifecycle.

Home-Use Connected Medical Devices

Home-use IoMT includes connected blood pressure monitors, pulse oximeters, scales, respiratory devices, sleep equipment, glucose monitors, thermometers, digital stethoscopes, home diagnostic technologies, and post-discharge monitoring kits.

This segment is positioned for above-market growth as healthcare delivery moves toward lower-cost settings. Product success depends heavily on usability, automatic connectivity, patient adherence, clinician dashboard integration, and reimbursement compatibility.

Portable and Point-of-Care Connected Devices

Portable ultrasound, mobile ECG, handheld diagnostic systems, connected vital-sign monitors, point-of-care testing devices, and other compact medical technologies form another high-growth category. These products allow diagnostic capability to move between hospital departments, ambulatory clinics, emergency environments, rural facilities, and patients’ homes.

By Application

Remote Patient Monitoring and Chronic Disease Management

Remote patient monitoring represents the largest IoMT application and is estimated to account for approximately 29% of the U.S. market in 2025. Cardiovascular disease, diabetes, hypertension, chronic respiratory disease, sleep disorders, and post-acute monitoring are major use cases.

The value proposition is strongest when remote information results in actionable intervention rather than simple data collection. Platforms capable of triaging patients and integrating monitoring into clinical workflows are therefore gaining preference over standalone devices.

Telemedicine and Virtual Care

Connected medical devices strengthen telemedicine by allowing clinicians to obtain objective physiological information during remote encounters. Connected stethoscopes, blood pressure systems, glucose monitors, pulse oximeters, otoscopes, ECG devices, and diagnostic kits extend virtual care beyond video consultation.

As virtual care matures, objective device-generated data will become increasingly important for differentiating clinically meaningful telemedicine from basic digital communication.

Hospital Clinical Workflow and Asset Management

IoMT is increasingly used for hospital operations. Connected devices, RFID, real-time location systems, smart beds, equipment telemetry, and environmental monitoring can improve asset utilization, reduce equipment-search time, support maintenance, monitor temperature-sensitive products, and improve operational visibility.

The economic argument is substantial for large health systems that operate tens of thousands of pieces of movable medical equipment.

Diagnostics, Imaging and Continuous Monitoring

Connected imaging systems, bedside monitoring, ambulatory cardiac diagnostics, digital pathology technologies, portable imaging, and AI-enabled diagnostic systems are becoming major IoMT endpoints. Connectivity allows studies to be routed, analyzed, archived, remotely reviewed, and integrated into clinical records.

AI is particularly important in this application because diagnostic devices generate complex information that can benefit from automated prioritization and interpretation.

Medication and Therapy Management

Connected infusion pumps, smart inhalers, automated insulin delivery systems, medication-adherence technologies, connected injectors, and digitally managed therapeutic devices are expanding the role of IoMT from observation into treatment.

This application has significant long-term potential because closed-loop systems can potentially detect a physiological need and adjust therapy according to predefined clinical parameters.

By End User

Hospitals and Integrated Health Systems

Hospitals and health systems represent the dominant end-user category, accounting for an estimated 44% of U.S. IoMT revenue in 2025. Their spending encompasses patient monitoring, connected imaging, smart infusion, clinical communication, device integration, asset tracking, cybersecurity, remote monitoring, and enterprise analytics.

Large integrated delivery networks increasingly negotiate enterprise agreements that standardize device platforms across multiple hospitals. Vendors that secure system-wide architecture positions can therefore create substantial recurring revenue and strong competitive barriers.

Homecare and Patients

Homecare represents one of the fastest-growing IoMT end-user groups. The commercial opportunity spans chronic disease monitoring, post-discharge care, sleep therapy, diabetes management, cardiac monitoring, respiratory care, rehabilitation, and aging-related monitoring.

The home environment requires a fundamentally different design philosophy from hospitals. Products must work reliably without clinical technicians, sophisticated Wi-Fi configuration, or frequent troubleshooting.

Physician Practices, Clinics and Ambulatory Centers

Outpatient settings are adopting connected diagnostic, monitoring, and therapeutic technologies as procedures and disease management move away from the hospital. Cardiology, endocrinology, pulmonology, primary care, orthopedics, and specialty clinics are major users.

These organizations often prioritize fast deployment, predictable subscription economics, reimbursement support, and low IT complexity.

Diagnostic Centers and Laboratories

Diagnostic organizations use connected equipment for imaging, laboratory testing, point-of-care diagnostics, ambulatory monitoring, and workflow automation. IoMT allows equipment utilization, test results, quality metrics, and diagnostic information to move across distributed clinical networks.

Pharmaceutical, Research, Payer and Life-Science Organizations

Connected medical devices are increasingly used in decentralized clinical trials, digital endpoints, medication adherence programs, outcomes research, population health, and risk management. Pharmaceutical companies can use medical-grade sensors to collect real-world evidence while payers can use connected-care programs to support high-risk populations.

Regional Insights: Where the Market is Growing Fastest

The U.S. Internet of Medical Things Market is geographically segmented into the South, West, Northeast, and Midwest. Regional performance differs according to population growth, age profile, health-system concentration, digital-health adoption, broadband availability, chronic disease burden, technology ecosystems, academic medical center density, payer structure, and hospital investment capacity.

The South represents the largest regional IoMT market in 2025, while the West is expected to record the fastest technology-led growth through 2035. The Northeast remains one of the highest-value markets for academic medicine and enterprise digital infrastructure, while the Midwest provides a large, stable base of integrated provider networks and medical-technology expertise.

South

The South represented an estimated USD 25.17 billion in 2025, accounting for approximately 32% of the U.S. IoMT market. The region includes Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, Maryland, Tennessee, Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, West Virginia, Delaware, and the District of Columbia under the report’s commercial regional framework.

Population scale is a major advantage. Texas reached approximately 31.7 million residents in 2025, making it the second-largest state population in the country, while Florida exceeded 23.4 million. Texas, Florida, North Carolina, Georgia, and South Carolina also continue to record strong population gains, expanding the addressable base for hospitals, ambulatory care, chronic disease monitoring, and home health.

Texas is one of the most important IoMT state markets nationally. Houston, Dallas-Fort Worth, Austin, and San Antonio contain major health systems, academic institutions, technology businesses, medical research organizations, and large populations of commercially insured and Medicare patients. Texas is particularly attractive for hospital connectivity, continuous patient monitoring, cardiac and diabetes technologies, tele-ICU infrastructure, remote monitoring, and home-centered care.

Florida is structurally important because of its large older population. Demand is particularly strong for connected cardiovascular monitoring, blood pressure technologies, diabetes management, sleep and respiratory platforms, post-acute monitoring, and home-use devices. Large hospital networks and physician groups can support multi-site IoMT deployment at scale.

North Carolina and Georgia are becoming increasingly important. North Carolina surpassed approximately 11.1 million residents in 2025 and combines rapid population growth with major academic medical centers, healthcare technology organizations, research institutions, and life-science clusters. Georgia exceeds approximately 11.3 million residents and benefits from Atlanta’s large healthcare-provider and technology ecosystem.

Virginia and Maryland provide another attractive cluster because of their sophisticated healthcare infrastructure, proximity to federal agencies, cybersecurity expertise, research organizations, and large integrated provider systems. Connected-device cybersecurity and federal digital-health standards have particular strategic relevance in this market.

Tennessee has strong hospital and healthcare-services infrastructure, while South Carolina is one of the country’s fastest-growing states by population. Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, and West Virginia have significant chronic disease burdens and rural populations, creating an important need for scalable connected monitoring and virtual specialist access.

By 2035, the South could represent approximately USD 113.28 billion in annual IoMT revenue under the report’s regional forecast model. Growth will be driven by population expansion, remote patient monitoring, chronic disease prevalence, hospital system consolidation, homecare, connected diabetes management, and investment in digitally integrated clinical infrastructure.

West

The West represented an estimated USD 21.24 billion in 2025, or approximately 27% of the national market, and is expected to be the fastest-growing region through 2035. The region includes California, Washington, Arizona, Colorado, Oregon, Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii.

California is the largest individual state opportunity in the region and one of the most influential IoMT markets globally. Its population exceeded 39.3 million in 2025, and the state combines major integrated health systems, academic medical centers, medical device manufacturers, semiconductor expertise, cloud-computing companies, artificial intelligence developers, digital-health startups, and venture investment.

California frequently acts as an early commercialization environment for connected medical technologies. The state is particularly strong in wearable health technology, continuous glucose monitoring, remote monitoring, AI-enabled diagnostics, digital therapeutics infrastructure, cloud-connected imaging, surgical technology, and home-based care.

Washington provides an important intersection between enterprise cloud infrastructure and healthcare delivery. Large technology businesses and sophisticated health systems support adoption of cloud-connected devices, clinical analytics, interoperability platforms, and AI-enabled care management.

Arizona and Nevada benefit from population growth and aging demographics. Arizona exceeded approximately 7.6 million residents in 2025, creating expanding demand for cardiovascular monitoring, diabetes devices, connected homecare, sleep technologies, and chronic disease management.

Colorado and Utah have strong digital-health ecosystems and technologically sophisticated provider organizations. Utah also remains one of the faster-growing states, supporting new healthcare infrastructure investment. Oregon has a mature integrated-care environment with meaningful adoption of connected population-health tools.

Idaho, Montana, Wyoming, Alaska, and New Mexico have smaller populations but provide an important use case for IoMT: geographic distance from specialist care. Remote diagnostics, connected monitoring, virtual specialty care, portable imaging, and home medical technologies can generate disproportionately high clinical value in rural and frontier areas.

The West is expected to increase its national market share as AI, sensor technology, cloud infrastructure, consumer-medical convergence, and decentralized care become increasingly important. Under the report model, regional IoMT revenue could approach approximately USD 105.97 billion by 2035.

Northeast

The Northeast represented an estimated USD 18.09 billion in 2025, equivalent to approximately 23% of the U.S. IoMT market. The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Maine, Vermont, New Hampshire, and Rhode Island.

New York is the largest Northeast market and had approximately 20.0 million residents in 2025. New York City and surrounding metropolitan areas support some of the country’s largest academic health systems, dense specialist networks, major payer organizations, research centers, and digitally sophisticated hospitals.

New York is especially important for enterprise patient monitoring, hospital command centers, connected imaging, virtual specialty care, cardiac monitoring, cybersecurity, and AI-enabled clinical workflow. Large health-system networks create opportunities for multi-hospital standardization.

Pennsylvania, with more than 13.0 million residents, has a large hospital base and major academic medical centers. Philadelphia and Pittsburgh provide strong markets for connected diagnostics, cardiac monitoring, medical-device integration, remote chronic disease management, and clinical research.

Massachusetts has a smaller population than New York or Pennsylvania but outsized strategic influence. Boston’s concentration of academic medicine, biotechnology, medtech, venture capital, software development, and clinical research makes the state a major early-adoption environment for IoMT technologies.

New Jersey combines a substantial healthcare market with one of the country’s strongest pharmaceutical and life-science clusters. This creates opportunities for connected medical devices not only in clinical care but also decentralized trials, digital biomarkers, adherence programs, and real-world evidence.

Connecticut, Rhode Island, New Hampshire, Vermont, and Maine are smaller markets. Nevertheless, aging populations and rural areas in northern New England support demand for remote monitoring, connected respiratory care, home diagnostics, and virtual specialist access.

Procurement in the Northeast tends to be evidence-intensive. Academic centers and large health systems frequently require interoperability validation, cybersecurity documentation, clinical evidence, workflow assessment, and clear economic justification before enterprise adoption. Vendors that establish reference accounts in this region can gain national credibility.

The Northeast is projected to remain a premium-value market and could generate approximately USD 80.39 billion in IoMT revenue by 2035.

Midwest

The Midwest accounted for an estimated USD 14.16 billion in 2025, representing approximately 18% of the national IoMT market. The region includes Illinois, Ohio, Michigan, Minnesota, Indiana, Wisconsin, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota.

Illinois represents the largest state opportunity in the region, supported by approximately 12.7 million residents and Chicago’s extensive hospital and academic medical ecosystem. Connected inpatient monitoring, imaging, device integration, ambulatory monitoring, and health-system analytics are major opportunities.

Ohio had approximately 11.9 million residents in 2025 and is strategically important because of its substantial hospital infrastructure and nationally influential specialty care institutions. Connected cardiac care, intensive-care monitoring, remote patient management, and clinical AI are attractive categories.

Michigan exceeds 10 million residents and provides a large addressable population for chronic disease monitoring, cardiovascular care, diabetes technologies, and hospital IoMT. Indiana, Wisconsin, and Missouri offer established provider networks and significant community-hospital demand.

Minnesota holds particularly strong strategic importance despite its smaller population because the state has one of the deepest medical-device ecosystems in the country. Expertise in cardiac devices, monitoring, implantables, and medtech engineering makes Minnesota relevant to both IoMT manufacturing and clinical adoption.

Iowa, Kansas, Nebraska, North Dakota, and South Dakota are smaller markets but illustrate why IoMT can have significant geographic value. Remote monitoring, telehealth-connected diagnostics, home devices, portable imaging, and virtual specialty support can help manage patients across broad rural catchment areas.

Midwestern procurement tends to reward clinically reliable, scalable, cost-efficient technology. Manufacturers that provide strong service infrastructure, dependable device integration, clinical education, and enterprise contracting can develop durable positions with regional health systems.

The Midwest is expected to retain a relatively stable national share, reaching approximately USD 65.78 billion by 2035 under the report forecast.

Key Market Players

The U.S. Internet of Medical Things competitive landscape is fragmented across medical device manufacturers, patient-monitoring specialists, digital-health companies, networking vendors, cloud platforms, analytics providers, and enterprise health technology companies.

Competition is increasingly ecosystem-based. Traditional medtech companies possess clinical credibility, regulated devices, distribution networks, and hospital relationships. Technology companies contribute cloud infrastructure, device management, cybersecurity, connectivity, artificial intelligence, and data architecture. Specialized digital-health companies compete through focused clinical workflows and more agile software development.

Some of the key players operating in the U.S. Internet of Medical Things industry include:

Abbott Laboratories
Medtronic
GE HealthCare Technologies Inc.
Koninklijke Philips N.V.
Siemens Healthineers
Boston Scientific Corporation
Johnson & Johnson MedTech
Baxter International Inc.
Becton, Dickinson and Company
Dexcom, Inc.
Insulet Corporation
ResMed Inc.
Masimo Corporation
iRhythm Technologies, Inc.
OMRON Healthcare
F. Hoffmann-La Roche Ltd.
Stryker Corporation
Cisco Systems, Inc.
Microsoft Corporation
Oracle Corporation
Honeywell International Inc.
Zebra Technologies Corporation
Qualcomm Technologies, Inc.
BioIntelliSense, Inc.
AliveCor, Inc.

Abbott, Medtronic, Dexcom, Insulet, Boston Scientific, iRhythm, ResMed, and Masimo have strong positions in clinically focused connected devices and monitoring ecosystems. GE HealthCare, Philips, Siemens Healthineers, Baxter, and BD are important in hospital-connected infrastructure, monitoring, diagnostics, infusion, and enterprise clinical workflows.

Cisco, Microsoft, Oracle, Honeywell, Zebra Technologies, and Qualcomm influence the enabling layer through networking, cloud architecture, healthcare data platforms, device connectivity, asset tracking, security, and wireless technologies. BioIntelliSense and AliveCor illustrate the role of specialist innovators targeting continuous monitoring and digitally enabled diagnostics.

Competitive performance through 2035 will depend on installed-device scale, clinical evidence, FDA authorization, interoperability, cybersecurity maturity, artificial intelligence capabilities, cloud architecture, reimbursement support, hospital contracting, data ownership models, physician acceptance, and the ability to demonstrate measurable operational or patient-outcome improvement.

Recent Developments

Recent U.S. market developments demonstrate that IoMT is moving toward a more regulated, intelligent, and home-oriented ecosystem.

In February 2026, the FDA issued updated final guidance addressing cybersecurity considerations for medical devices and section 524B requirements for cyber devices. The regulatory direction reinforces cybersecurity as a total-product-lifecycle responsibility and increases the importance of vulnerability management, secure development, software-component transparency, post-market updates, and coordinated response processes.

The FDA has also continued expanding public visibility into AI-enabled medical devices, with authorizations extending across radiology, cardiovascular medicine, pathology, neurology, ultrasound, and other specialties. This is directly relevant to IoMT because increasingly connected diagnostic systems are being designed not only to transmit information but also to interpret and prioritize it.

Sensor-based digital health technologies have gained additional regulatory attention. FDA-authorized wearable and minimally invasive technologies now include devices designed for monitoring patients outside conventional clinical settings. This development supports the transition of IoMT from hospital-centered connectivity toward continuous monitoring across everyday environments.

Continuous glucose monitoring remains one of the most important proof points for connected medical care. Advances in sensor wear duration, smartphone integration, automated insulin delivery, accessibility, and consumer-friendly distribution are expanding the role of continuous physiological data in diabetes management.

Cardiovascular monitoring continues to evolve through wearable ECG, Holter platforms, implantable monitoring, connected rhythm-management devices, and AI-supported interpretation. These technologies can reduce dependence on brief in-office diagnostic windows and support earlier identification of clinically significant events.

Hospital systems are simultaneously strengthening connected-device cybersecurity programs. Procurement organizations are increasingly asking vendors for software bills of materials, vulnerability-management policies, patching processes, device-support timelines, network requirements, encryption practices, and integration documentation. Cybersecurity performance is therefore becoming part of commercial differentiation.

Home-use medical devices represent another strategic frontier. Regulators and manufacturers are paying greater attention to usability, human factors, remote support, home connectivity, and safe operation outside professional clinical environments. This supports a long-term shift toward hospital-at-home, post-discharge monitoring, decentralized diagnostics, and chronic disease management.

The market is also moving toward fewer isolated dashboards. Health systems increasingly want device information integrated into electronic health records, command centers, clinical communication systems, and population-health workflows. This is encouraging partnerships between medical device companies, cloud providers, interoperability vendors, and enterprise software companies.

Over the next several years, acquisition activity is likely to remain strong as large medtech manufacturers pursue specialized sensor, AI, cybersecurity, remote monitoring, and analytics capabilities. The strategic objective will increasingly be to own a larger portion of the connected patient pathway rather than only the physical device.

Conclusion

The U.S. Internet of Medical Things Market Size & Share is positioned for substantial expansion from approximately USD 78.67 billion in 2025 to USD 365.42 billion by 2035, representing a 16.60% CAGR during 2026–2035. The historical market increased from approximately USD 42.56 billion in 2021 to USD 67.47 billion in 2024, demonstrating that connected medical infrastructure has already moved well beyond early-stage adoption.

The market’s long-term strength is supported by the scale of U.S. healthcare expenditure, an aging population, high chronic disease prevalence, hospital digital transformation, remote patient monitoring reimbursement, outpatient migration, home-based care, artificial intelligence, and greater demand for clinician productivity.

The highest-value opportunities will not necessarily belong to companies producing the largest number of connected devices. Value will increasingly concentrate around companies capable of transforming device-generated information into clinically useful actions. Interoperability, workflow integration, cybersecurity, analytics, artificial intelligence, evidence generation, and recurring service models will therefore become increasingly important components of competitive advantage.

Hospitals will remain the largest end-user group, but homecare will capture an increasing proportion of incremental market growth. Remote patient monitoring, connected cardiovascular care, continuous glucose monitoring, respiratory monitoring, AI-supported diagnostics, smart hospital infrastructure, and connected medication delivery represent especially attractive growth areas.

Regionally, the South leads the market based on population scale, hospital expansion, aging demographics, and chronic disease demand. The West is expected to record the fastest technology-driven growth, supported by California’s medical technology ecosystem and strong digital-health adoption. The Northeast will remain a premium market for academic medicine, enterprise health IT, and evidence-intensive adoption, while the Midwest provides a large and stable base of integrated health systems, medical-device expertise, and remote-care opportunities.

Texas, California, Florida, New York, Pennsylvania, Illinois, Ohio, North Carolina, Georgia, Massachusetts, New Jersey, Michigan, Washington, Arizona, Minnesota, and Virginia are expected to remain especially important state markets for IoMT suppliers through the forecast period.

For medical device manufacturers, investors, hospital technology executives, and healthcare strategy teams evaluating the U.S. IoMT opportunity, the core question is increasingly not whether medical devices will become connected. That transition is already underway. The strategic questions are which connected workflows will demonstrate sufficient clinical and economic value to achieve enterprise-scale adoption, which companies will control the data and integration layer, how cybersecurity requirements will reshape product development economics, and which device ecosystems will become embedded deeply enough in clinical operations to create durable recurring revenue.

By 2035, the U.S. Internet of Medical Things market will increasingly function as infrastructure rather than a standalone technology category. Connected medical devices, software, artificial intelligence, cloud environments, cybersecurity, and clinical workflows will converge into integrated care platforms. Companies that can deliver clinically validated devices while reducing workflow friction, protecting patient data, supporting reimbursement, demonstrating measurable outcomes, and operating seamlessly across hospital and home environments will be best positioned to define the next decade of connected healthcare in the United States.

TABLE OF CONTENT

1. U.S. Internet of Medical Things Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Market Sizing, Triangulation & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Connected Medical Device Manufacturers
1.6.2. Medical Sensor, Semiconductor and Connectivity Component Suppliers
1.6.3. IoMT Software, Cloud and Data Platform Providers
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Physician Practices, Ambulatory Centers and Diagnostic Providers
1.6.6. Home Healthcare and Remote Patient Monitoring Providers
1.6.7. Health Insurers and Value-Based Care Organizations
1.6.8. Healthcare IT, Cybersecurity and Interoperability Vendors
1.6.9. FDA, CMS and Other Regulatory Stakeholders
1.6.10. Patients and Caregivers

What this section provides: This section defines the U.S. Internet of Medical Things market boundary, study scope, research methodology, analytical assumptions, and stakeholder ecosystem so clients understand how connected medical devices, IoMT platforms, services, and care-delivery applications are measured and validated.

2. U.S. Internet of Medical Things Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. U.S. Internet of Medical Things Market Size, 2021–2035 (US$ Billion)
2.8. CAGR Analysis, 2026–2035
2.9. High-Growth Opportunity Areas
2.9.1. Remote Patient Monitoring
2.9.2. Connected Diabetes Management
2.9.3. Continuous Cardiac Monitoring
2.9.4. Smart Hospital Infrastructure
2.9.5. Connected Home Healthcare
2.9.6. AI-Enabled Connected Medical Devices
2.9.7. Medical Device Cybersecurity
2.9.8. Clinical Device Interoperability

What this section provides: This section gives decision-makers a concise view of U.S. IoMT market size, historical development, forecast trajectory, competitive intensity, technology shifts, and priority investment opportunities through 2035.

3. U.S. Internet of Medical Things Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Increasing U.S. Chronic Disease Burden
3.1.2. Rapid Expansion of Remote Patient Monitoring
3.1.3. Rising Adoption of Connected Medical Devices
3.1.4. Aging U.S. Population and Home-Based Care Demand
3.1.5. Hospital Digital Transformation and Smart Hospital Investment
3.1.6. Increasing Healthcare Workforce and Clinical Productivity Pressure
3.1.7. Expansion of Value-Based Care Models
3.1.8. Growing Adoption of AI-Enabled Clinical Monitoring
3.1.9. Increasing Integration of Medical Devices with EHR Platforms
3.2. Restraints and Their Impact Analysis
3.2.1. Medical Device Cybersecurity Risks
3.2.2. High IoMT Deployment and Integration Costs
3.2.3. Legacy Hospital IT Infrastructure
3.2.4. Device Interoperability Challenges
3.2.5. Patient Data Privacy and HIPAA Compliance Requirements
3.2.6. Fragmented Device and Software Ecosystems
3.2.7. Reimbursement Variability Across Connected-Care Models
3.3. Opportunities and Their Impact Analysis
3.3.1. Hospital-at-Home and Acute Care at Home
3.3.2. Connected Chronic Disease Management
3.3.3. AI-Powered Predictive Monitoring
3.3.4. Digital Biomarkers and Continuous Physiologic Monitoring
3.3.5. Decentralized Clinical Trials
3.3.6. Edge Computing in Medical Devices
3.3.7. 5G and Advanced Wireless Healthcare Connectivity
3.3.8. Closed-Loop Therapeutic Systems
3.3.9. Rural and Underserved Population Monitoring
3.4. Challenges and Their Impact Analysis
3.4.1. Alert Fatigue and Clinical Data Overload
3.4.2. Medical Device Lifecycle Management
3.4.3. Software Patch and Vulnerability Management
3.4.4. Patient Engagement and Technology Adherence
3.4.5. Hospital Integration Complexity
3.4.6. Connectivity Reliability Outside Clinical Facilities
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Hospital Digital Capital Procurement Behavior Analysis
3.8. Connected Device Total Cost of Ownership Analysis
3.9. IoMT Return-on-Investment Framework
3.10. Remote Monitoring Economics and Avoidable Utilization Analysis

What this section provides: This section explains the clinical, technological, regulatory, reimbursement, cybersecurity, and operational forces shaping IoMT demand and enables clients to evaluate market upside, adoption barriers, workflow impact, and execution risks.

4. U.S. Internet of Medical Things Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Healthcare Buyers
4.2.3. Bargaining Power of Technology and Component Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. IoMT Pricing Trend Analysis, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Medical Sensor and Semiconductor Supply Landscape
4.6. Connectivity Infrastructure Landscape
4.6.1. Wi-Fi-Enabled Medical Devices
4.6.2. Bluetooth and Bluetooth Low Energy
4.6.3. Cellular Connectivity
4.6.4. 5G-Enabled Healthcare Connectivity
4.6.5. Near-Field Communication and RFID
4.6.6. Low-Power Wide-Area Networks
4.7. Cloud and Edge Computing Landscape
4.8. Healthcare Data Interoperability Landscape
4.8.1. EHR Integration
4.8.2. HL7 and FHIR-Based Connectivity
4.8.3. Medical Device Integration Platforms
4.8.4. API-Based Healthcare Data Exchange
4.9. Artificial Intelligence & Machine Learning Impact Analysis
4.10. FDA Medical Device Regulatory Framework Analysis
4.11. FDA Cybersecurity Requirements for Connected Medical Devices
4.12. CMS Reimbursement and Remote Patient Monitoring Landscape
4.13. HIPAA and Healthcare Data Privacy Analysis
4.14. Software Bill of Materials and Vulnerability Management Landscape
4.15. Government Digital Health Initiatives
4.16. Import/Export Restrictions, Semiconductor Supply and Tariff Impact
4.17. Impact of Escalating Geopolitical and Cybersecurity Tensions
4.18. Hospital Value Analysis Committee Decision Framework
4.19. Enterprise IoMT Procurement and Vendor Consolidation Trends

What this section provides: This section gives clients a comprehensive view of the external IoMT market environment, including regulation, cybersecurity, reimbursement, interoperability, cloud infrastructure, AI adoption, connectivity, supply chains, pricing, and enterprise procurement dynamics.

5. U.S. Internet of Medical Things Market – By Component

5.1. Overview
5.1.1. Segment Share Analysis, By Component, 2025 & 2035 (%)
5.1.2. Hardware
5.1.2.1. Medical Sensors
5.1.2.2. Wearable Medical Hardware
5.1.2.3. Connected Patient Monitoring Devices
5.1.2.4. Network Gateways
5.1.2.5. Communication Modules
5.1.2.6. Smart Medical Equipment
5.1.2.7. Other IoMT Hardware
5.1.3. Software & Platforms
5.1.3.1. Medical Device Management Software
5.1.3.2. Remote Patient Monitoring Platforms
5.1.3.3. Clinical Data Integration Platforms
5.1.3.4. IoMT Analytics Software
5.1.3.5. Cloud-Based Medical Device Platforms
5.1.3.6. AI-Enabled Clinical Analytics
5.1.3.7. Medical Device Cybersecurity Software
5.1.4. Services
5.1.4.1. Implementation & Integration Services
5.1.4.2. Consulting Services
5.1.4.3. Managed Connectivity Services
5.1.4.4. Cloud Hosting Services
5.1.4.5. Cybersecurity & Vulnerability Management Services
5.1.4.6. Maintenance & Technical Support
5.1.4.7. Training & Clinical Workflow Optimization

What this section provides: This section identifies how IoMT revenue is distributed across hardware, software, platforms, and services and evaluates which components are expected to generate the strongest recurring revenue and growth through 2035.

6. U.S. Internet of Medical Things Market – By Device Type

6.1. Overview
6.1.1. Segment Share Analysis, By Device Type, 2025 & 2035 (%)
6.1.2. On-Body and Wearable Medical Devices
6.1.2.1. Continuous Glucose Monitors
6.1.2.2. Wearable ECG and Cardiac Monitoring Devices
6.1.2.3. Connected Blood Pressure Monitors
6.1.2.4. Wearable Pulse Oximeters
6.1.2.5. Sleep Monitoring Devices
6.1.2.6. Medical-Grade Smartwatches and Sensor Patches
6.1.2.7. Other Wearable Medical Devices
6.1.3. Stationary Connected Medical Devices
6.1.3.1. Bedside Patient Monitoring Systems
6.1.3.2. Smart Infusion Pumps
6.1.3.3. Connected Ventilators
6.1.3.4. Connected Imaging Systems
6.1.3.5. Smart Beds
6.1.3.6. Connected Dialysis Systems
6.1.3.7. Laboratory and Diagnostic Equipment
6.1.4. Implantable Connected Medical Devices
6.1.4.1. Connected Pacemakers
6.1.4.2. Implantable Cardioverter Defibrillators
6.1.4.3. Implantable Cardiac Monitors
6.1.4.4. Connected Neuromodulation Devices
6.1.4.5. Implantable Therapeutic Monitoring Systems
6.1.4.6. Other Implantable IoMT Devices
6.1.5. Home-Use Connected Medical Devices
6.1.5.1. Connected Glucose Monitoring Systems
6.1.5.2. Home Blood Pressure Monitors
6.1.5.3. Connected Pulse Oximeters
6.1.5.4. Connected Weighing Scales
6.1.5.5. CPAP and Respiratory Monitoring Systems
6.1.5.6. Connected Thermometers
6.1.5.7. Home Diagnostic Devices
6.1.6. Portable and Point-of-Care Connected Devices
6.1.6.1. Portable Ultrasound Systems
6.1.6.2. Mobile ECG Systems
6.1.6.3. Handheld Diagnostic Systems
6.1.6.4. Portable Vital-Sign Monitors
6.1.6.5. Point-of-Care Testing Devices

What this section provides: This section evaluates IoMT demand across wearable, stationary, implantable, home-use, and portable connected medical technologies and highlights device categories with the strongest adoption and commercial potential.

7. U.S. Internet of Medical Things Market – By Application

7.1. Overview
7.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
7.1.2. Remote Patient Monitoring & Chronic Disease Management
7.1.2.1. Cardiovascular Monitoring
7.1.2.2. Diabetes Management
7.1.2.3. Hypertension Management
7.1.2.4. Respiratory Disease Monitoring
7.1.2.5. Neurological Monitoring
7.1.2.6. Post-Discharge Monitoring
7.1.2.7. Elderly and High-Risk Patient Monitoring
7.1.3. Telemedicine & Virtual Care
7.1.3.1. Virtual Primary Care
7.1.3.2. Virtual Specialty Care
7.1.3.3. Rural Telemedicine
7.1.3.4. Hospital-at-Home Programs
7.1.3.5. Connected Diagnostic Telemedicine
7.1.4. Hospital Clinical Workflow & Asset Management
7.1.4.1. Smart Patient Monitoring
7.1.4.2. Medical Equipment Tracking
7.1.4.3. Smart Bed Management
7.1.4.4. Connected Infusion Management
7.1.4.5. Predictive Equipment Maintenance
7.1.4.6. Clinical Alarm Management
7.1.4.7. Automated Device Data Documentation
7.1.5. Diagnostics, Imaging & Continuous Monitoring
7.1.5.1. Connected Medical Imaging
7.1.5.2. Ambulatory Cardiac Diagnostics
7.1.5.3. Continuous Physiological Monitoring
7.1.5.4. AI-Enabled Diagnostic Monitoring
7.1.5.5. Connected Point-of-Care Diagnostics
7.1.6. Medication & Therapy Management
7.1.6.1. Smart Infusion Therapy
7.1.6.2. Automated Insulin Delivery
7.1.6.3. Connected Inhalers
7.1.6.4. Connected Drug-Delivery Devices
7.1.6.5. Medication Adherence Monitoring
7.1.6.6. Closed-Loop Therapeutic Systems

What this section provides: This section helps clients understand IoMT demand by clinical and operational use case and identifies applications with strong reimbursement relevance, workflow value, recurring monitoring economics, and technology adoption potential.

8. U.S. Internet of Medical Things Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Hospitals & Integrated Health Systems
8.1.2.1. Academic Medical Centers
8.1.2.2. Large Integrated Delivery Networks
8.1.2.3. Community Hospitals
8.1.2.4. Specialty Hospitals
8.1.2.5. Critical Access and Rural Hospitals
8.1.3. Homecare Providers & Patients
8.1.3.1. Home Healthcare Agencies
8.1.3.2. Remote Patient Monitoring Providers
8.1.3.3. Hospital-at-Home Programs
8.1.3.4. Individual Patients and Caregivers
8.1.4. Physician Practices, Clinics & Ambulatory Centers
8.1.4.1. Primary Care Practices
8.1.4.2. Cardiology Practices
8.1.4.3. Endocrinology and Diabetes Clinics
8.1.4.4. Pulmonology and Sleep Clinics
8.1.4.5. Ambulatory Surgery Centers
8.1.4.6. Multispecialty Physician Groups
8.1.5. Diagnostic Centers & Laboratories
8.1.5.1. Medical Imaging Centers
8.1.5.2. Clinical Laboratories
8.1.5.3. Ambulatory Diagnostic Monitoring Providers
8.1.5.4. Point-of-Care Testing Providers
8.1.6. Pharmaceutical, Research, Payer & Life-Science Organizations
8.1.6.1. Pharmaceutical Companies
8.1.6.2. Contract Research Organizations
8.1.6.3. Decentralized Clinical Trial Providers
8.1.6.4. Health Insurers
8.1.6.5. Accountable Care and Value-Based Care Organizations

What this section provides: This section explains which U.S. care settings and customer groups will drive connected-device purchasing, platform adoption, recurring monitoring utilization, and IoMT infrastructure investment through 2035.

9. U.S. Internet of Medical Things Market – By Geography

9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
9.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
9.1.3. Regional Connected Device Adoption Analysis
9.1.4. Regional Hospital Digital Infrastructure Analysis
9.1.5. Regional Remote Patient Monitoring Adoption Analysis
9.1.6. Regional Chronic Disease and Aging Population Analysis
9.1.7. Regional Healthcare IT and IoMT Investment Analysis
9.1.8. Regional Reimbursement and Enterprise Procurement Dynamics
9.2. West Region
9.2.1. Regional Overview & Trends
9.2.2. West Region IoMT Key Manufacturers, Technology Providers and Healthcare Ecosystem
9.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.2.4. West Region Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.5. West Region Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.2.6. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.8. West Region Digital Health Innovation and Investment Analysis
9.2.9. California
9.2.9.1. Overview
9.2.9.2. California Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.9.3. California Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.2.9.4. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.9.5. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.10. Washington
9.2.10.1. Overview
9.2.10.2. Washington Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.10.3. Washington Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.2.10.4. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.11. Arizona
9.2.11.1. Overview
9.2.11.2. Arizona Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.11.3. Arizona Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.2.11.4. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.12. Colorado
9.2.12.1. Overview
9.2.12.2. Colorado Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.12.3. Colorado Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.2.12.4. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.13. Oregon
9.2.13.1. Overview
9.2.13.2. Oregon Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.13.3. Oregon Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.2.13.4. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.14. Utah
9.2.14.1. Overview
9.2.14.2. Utah Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.14.3. Utah Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.2.14.4. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.15. Nevada
9.2.15.1. Overview
9.2.15.2. Nevada Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.15.3. Nevada Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.2.15.4. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.16. New Mexico
9.2.16.1. Overview
9.2.16.2. New Mexico Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.16.3. New Mexico Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.2.16.4. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.17. Idaho
9.2.17.1. Overview
9.2.17.2. Idaho Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.17.3. Idaho Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.2.17.4. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.18. Montana
9.2.18.1. Overview
9.2.18.2. Montana Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.18.3. Montana Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.2.18.4. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.19. Wyoming
9.2.19.1. Overview
9.2.19.2. Wyoming Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.19.3. Wyoming Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.2.19.4. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.20. Alaska
9.2.20.1. Overview
9.2.20.2. Alaska Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.20.3. Alaska Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.2.20.4. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.21. Hawaii
9.2.21.1. Overview
9.2.21.2. Hawaii Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.2.21.3. Hawaii Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.2.21.4. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3. Northeast Region
9.3.1. Regional Overview & Trends
9.3.2. Northeast Region IoMT Key Manufacturers, Technology Providers and Healthcare Ecosystem
9.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.3.4. Northeast Region Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.3.5. Northeast Region Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.3.6. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.8. Northeast Academic Medical Center and Digital Health Innovation Analysis
9.3.9. New York
9.3.9.1. Overview
9.3.9.2. New York Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.3.9.3. New York Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.3.9.4. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.9.5. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.10. Massachusetts
9.3.10.1. Overview
9.3.10.2. Massachusetts Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.3.10.3. Massachusetts Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.3.10.4. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.11. New Jersey
9.3.11.1. Overview
9.3.11.2. New Jersey Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.3.11.3. New Jersey Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.3.11.4. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.12. Pennsylvania
9.3.12.1. Overview
9.3.12.2. Pennsylvania Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.3.12.3. Pennsylvania Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.3.12.4. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.13. Connecticut
9.3.13.1. Overview
9.3.13.2. Connecticut Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.3.13.3. Connecticut Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.3.13.4. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.14. Maine
9.3.14.1. Overview
9.3.14.2. Maine Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.3.14.3. Maine Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.3.14.4. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.15. Vermont
9.3.15.1. Overview
9.3.15.2. Vermont Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.3.15.3. Vermont Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.3.15.4. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.16. New Hampshire
9.3.16.1. Overview
9.3.16.2. New Hampshire Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.3.16.3. New Hampshire Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.3.16.4. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.17. Rhode Island
9.3.17.1. Overview
9.3.17.2. Rhode Island Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.3.17.3. Rhode Island Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.3.17.4. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.18. Delaware
9.3.18.1. Overview
9.3.18.2. Delaware Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.3.18.3. Delaware Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.3.18.4. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.18.5. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4. South Region
9.4.1. Regional Overview & Trends
9.4.2. South Region IoMT Key Manufacturers, Technology Providers and Healthcare Ecosystem
9.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.4.4. South Region Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.5. South Region Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.4.6. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.7. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.8. South Region Chronic Disease, Aging Population and Remote Care Opportunity Analysis
9.4.9. Texas
9.4.9.1. Overview
9.4.9.2. Texas Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.9.3. Texas Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.4.9.4. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.10. Florida
9.4.10.1. Overview
9.4.10.2. Florida Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.10.3. Florida Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.4.10.4. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.11. Georgia
9.4.11.1. Overview
9.4.11.2. Georgia Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.11.3. Georgia Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.4.11.4. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.12. North Carolina
9.4.12.1. Overview
9.4.12.2. North Carolina Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.12.3. North Carolina Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.4.12.4. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.13. Tennessee
9.4.13.1. Overview
9.4.13.2. Tennessee Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.13.3. Tennessee Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.4.13.4. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.14. South Carolina
9.4.14.1. Overview
9.4.14.2. South Carolina Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.14.3. South Carolina Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.4.14.4. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.15. Alabama
9.4.15.1. Overview
9.4.15.2. Alabama Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.15.3. Alabama Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.4.15.4. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.16. Mississippi
9.4.16.1. Overview
9.4.16.2. Mississippi Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.16.3. Mississippi Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.4.16.4. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.17. Louisiana
9.4.17.1. Overview
9.4.17.2. Louisiana Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.17.3. Louisiana Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.4.17.4. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.18. Arkansas
9.4.18.1. Overview
9.4.18.2. Arkansas Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.18.3. Arkansas Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.4.18.4. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.19. Kentucky
9.4.19.1. Overview
9.4.19.2. Kentucky Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.19.3. Kentucky Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.4.19.4. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.20. Oklahoma
9.4.20.1. Overview
9.4.20.2. Oklahoma Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.20.3. Oklahoma Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.4.20.4. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.21. Virginia
9.4.21.1. Overview
9.4.21.2. Virginia Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.21.3. Virginia Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.4.21.4. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.22. Maryland
9.4.22.1. Overview
9.4.22.2. Maryland Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.22.3. Maryland Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.4.22.4. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.23. West Virginia
9.4.23.1. Overview
9.4.23.2. West Virginia Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.4.23.3. West Virginia Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.4.23.4. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5. Midwest Region
9.5.1. Regional Overview & Trends
9.5.2. Midwest Region IoMT Key Manufacturers, Technology Providers and Healthcare Ecosystem
9.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.5.4. Midwest Region Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.5. Midwest Region Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.5.6. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.8. Midwest Medical Device Manufacturing and Rural Connected-Care Analysis
9.5.9. Illinois
9.5.9.1. Overview
9.5.9.2. Illinois Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.9.3. Illinois Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.5.9.4. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.10. Ohio
9.5.10.1. Overview
9.5.10.2. Ohio Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.10.3. Ohio Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.5.10.4. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.11. Michigan
9.5.11.1. Overview
9.5.11.2. Michigan Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.11.3. Michigan Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.5.11.4. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.12. Minnesota
9.5.12.1. Overview
9.5.12.2. Minnesota Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.12.3. Minnesota Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.5.12.4. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.13. Indiana
9.5.13.1. Overview
9.5.13.2. Indiana Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.13.3. Indiana Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.5.13.4. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.14. Wisconsin
9.5.14.1. Overview
9.5.14.2. Wisconsin Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.14.3. Wisconsin Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.5.14.4. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.15. Missouri
9.5.15.1. Overview
9.5.15.2. Missouri Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.15.3. Missouri Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.5.15.4. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.16. Iowa
9.5.16.1. Overview
9.5.16.2. Iowa Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.16.3. Iowa Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.5.16.4. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.17. Kansas
9.5.17.1. Overview
9.5.17.2. Kansas Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.17.3. Kansas Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.5.17.4. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.18. Nebraska
9.5.18.1. Overview
9.5.18.2. Nebraska Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.18.3. Nebraska Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.5.18.4. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.19. North Dakota
9.5.19.1. Overview
9.5.19.2. North Dakota Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.19.3. North Dakota Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.5.19.4. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.20. South Dakota
9.5.20.1. Overview
9.5.20.2. South Dakota Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
9.5.20.3. South Dakota Market Size and Forecast, By Device Type, 2021–2035 (US$ Billion)
9.5.20.4. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level analysis for all 50 U.S. states, enabling clients to identify IoMT adoption hotspots, hospital digital-investment hubs, remote monitoring opportunities, technology clusters, chronic-disease demand centers, and priority commercial geographies.

10. U.S. Internet of Medical Things Market: Competitive Landscape & Company Profiles

10.1. Market Share Analysis, 2025
10.2. Competitive Benchmarking
10.3. Company Positioning Matrix
10.3.1. Leaders
10.3.2. Challengers
10.3.3. Innovators
10.3.4. Emerging Players
10.4. Competitive Positioning by Connected Medical Device Portfolio
10.5. Competitive Positioning by IoMT Software & Platform Capability
10.6. Competitive Positioning by Hospital Installed Base
10.7. Competitive Positioning by Remote Patient Monitoring Capability
10.8. Competitive Positioning by AI & Analytics Capability
10.9. Competitive Positioning by Cybersecurity & Interoperability Readiness
10.10. Company Profiles
10.10.1. Abbott Laboratories
10.10.2. Medtronic
10.10.3. GE HealthCare Technologies Inc.
10.10.4. Koninklijke Philips N.V.
10.10.5. Siemens Healthineers
10.10.6. Boston Scientific Corporation
10.10.7. Johnson & Johnson MedTech
10.10.8. Baxter International Inc.
10.10.9. Becton, Dickinson and Company
10.10.10. Dexcom, Inc.
10.10.11. Insulet Corporation
10.10.12. ResMed Inc.
10.10.13. Masimo Corporation
10.10.14. iRhythm Technologies, Inc.
10.10.15. OMRON Healthcare
10.10.16. F. Hoffmann-La Roche Ltd.
10.10.17. Stryker Corporation
10.10.18. Cisco Systems, Inc.
10.10.19. Microsoft Corporation
10.10.20. Oracle Corporation
10.10.21. Honeywell International Inc.
10.10.22. Zebra Technologies Corporation
10.10.23. Qualcomm Technologies, Inc.
10.10.24. BioIntelliSense, Inc.
10.10.25. AliveCor, Inc.
10.11. Company Profile Coverage Framework
10.11.1. Company Overview
10.11.2. IoMT Product & Platform Portfolio
10.11.3. U.S. Market Strategy
10.11.4. Connected Device Installed Base
10.11.5. Financial Positioning
10.11.6. AI, Software and Analytics Capabilities
10.11.7. Cybersecurity & Interoperability Strategy
10.11.8. FDA and Regulatory Developments
10.11.9. Partnerships, Acquisitions and Strategic Alliances
10.11.10. Recent Developments

What this section provides: This section gives clients competitor benchmarking, market-share visibility, connected-device portfolio positioning, platform capability analysis, digital strategy intelligence, innovation direction, and strategic profiling of 25 major IoMT market participants.

11. U.S. Internet of Medical Things Market: Future Market Outlook, 2026–2035

11.1. Scenario Analysis
11.1.1. Optimistic Scenario
11.1.2. Realistic Scenario
11.1.3. Pessimistic Scenario
11.2. Disruptive Technologies Impact
11.2.1. AI-Enabled Connected Medical Devices
11.2.2. Predictive Patient Monitoring
11.2.3. Edge AI and Edge Computing
11.2.4. 5G-Enabled Medical Connectivity
11.2.5. Digital Biomarkers
11.2.6. Continuous Physiological Monitoring
11.2.7. Closed-Loop Therapeutic Systems
11.2.8. Medical-Grade Wearables and Biosensors
11.2.9. Software-Defined Medical Devices
11.2.10. Digital Twins in Healthcare
11.2.11. Ambient Clinical Intelligence
11.2.12. Autonomous Clinical Monitoring Systems
11.3. Future of Smart Hospitals
11.4. Future of Hospital-at-Home IoMT
11.5. Future of Remote Patient Monitoring Reimbursement
11.6. Future Medical Device Cybersecurity Requirements
11.7. Cloud-to-Edge IoMT Architecture Evolution
11.8. Emerging Business Models
11.8.1. Device-as-a-Service
11.8.2. Monitoring-as-a-Service
11.8.3. Subscription-Based Medical Device Platforms
11.8.4. Outcomes-Based Connected Care Contracts
11.8.5. Risk-Sharing Agreements
11.9. Business Opportunities for Startups and Existing Players
11.10. Investment Prioritization Matrix
11.11. High-Growth Technology Opportunity Matrix
11.12. High-Growth Clinical Application Opportunity Matrix
11.13. High-Growth State Opportunity Matrix

What this section provides: This section prepares clients for future technology shifts, IoMT architecture changes, new business models, reimbursement evolution, cybersecurity requirements, and investment opportunities through 2035.

12. U.S. Internet of Medical Things Market: Strategic Recommendations

12.1. Recommendations for Connected Medical Device Manufacturers
12.2. Recommendations for IoMT Software & Platform Providers
12.3. Recommendations for Hospitals and Integrated Health Systems
12.4. Recommendations for Remote Patient Monitoring Providers
12.5. Recommendations for Investors and Private Equity Firms
12.6. Recommendations for Healthcare IT and Cloud Providers
12.7. Recommendations for Semiconductor, Sensor and Connectivity Companies
12.8. Recommendations for Health Insurers and Value-Based Care Organizations
12.9. Recommendations for New Entrants and Startups
12.10. Go-to-Market Strategy Considerations
12.11. Product Positioning and Portfolio Expansion Guidance
12.12. Hospital Enterprise Sales Strategy
12.13. Cybersecurity Differentiation Strategy
12.14. Interoperability and EHR Integration Strategy
12.15. Remote Patient Monitoring Commercialization Strategy
12.16. Partnership, Acquisition and Ecosystem Strategy
12.17. State-Level Market Entry Prioritization

What this section provides: This section converts IoMT market intelligence into actionable strategy for connected-device development, hospital commercialization, platform positioning, investment prioritization, geographic expansion, partnerships, cybersecurity differentiation, and long-term competitive growth.

13. U.S. Internet of Medical Things Market: Disclaimer

13.1. Scope Limitation
13.2. Data Use Limitation
13.3. Market Sizing Limitation
13.4. Forecasting Limitation
13.5. Technology Adoption Limitation
13.6. Regulatory and Reimbursement Limitation
13.7. Company Information Limitation
13.8. Legal Disclaimer
13.9. Third-Party Data Disclaimer

What this section provides: This section clarifies the report’s market-scope limitations, data-use conditions, forecasting assumptions, regulatory uncertainties, technology-adoption considerations, and legal boundaries.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Internet of Medical Things Market: Market Definition and Scope
TABLE 3: U.S. Internet of Medical Things Market: Research Methodology Framework
TABLE 4: U.S. Internet of Medical Things Market: Key Assumptions
TABLE 5: U.S. Internet of Medical Things Market: Market Ecosystem Overview
TABLE 6: U.S. Internet of Medical Things Market: Stakeholder Analysis
TABLE 7: U.S. Internet of Medical Things Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Internet of Medical Things Market: Analyst Viewpoint Summary
TABLE 9: U.S. Internet of Medical Things Market: Market Attractiveness Index
TABLE 10: U.S. Internet of Medical Things Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Internet of Medical Things Market: Base Year Market Positioning, 2025
TABLE 12: U.S. Internet of Medical Things Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 13: U.S. Internet of Medical Things Market: High-Growth Opportunity Areas
TABLE 14: U.S. Internet of Medical Things Market: Drivers; Impact Analysis
TABLE 15: U.S. Internet of Medical Things Market: Restraints; Impact Analysis
TABLE 16: U.S. Internet of Medical Things Market: Opportunities; Impact Analysis
TABLE 17: U.S. Internet of Medical Things Market: Challenges; Impact Analysis
TABLE 18: U.S. Internet of Medical Things Market: Patent & Innovation Analysis, 2021–2025
TABLE 19: U.S. Internet of Medical Things Market: Clinical Workflow Economics Matrix
TABLE 20: U.S. Internet of Medical Things Market: Hospital Digital Capital Procurement Behavior Matrix
TABLE 21: U.S. Internet of Medical Things Market: Connected Device Total Cost of Ownership Analysis
TABLE 22: U.S. Internet of Medical Things Market: IoMT Return-on-Investment Framework
TABLE 23: U.S. Internet of Medical Things Market: Remote Monitoring Economics Analysis
TABLE 24: U.S. Internet of Medical Things Market: Avoidable Healthcare Utilization Impact Matrix
TABLE 25: U.S. Internet of Medical Things Market: PESTEL Analysis
TABLE 26: U.S. Internet of Medical Things Market: Porter’s Five Forces Analysis
TABLE 27: U.S. Internet of Medical Things Market: Pricing Trend Analysis, 2025–2035
TABLE 28: U.S. Internet of Medical Things Market: Value Chain Analysis
TABLE 29: U.S. Internet of Medical Things Market: Supply Chain Analysis
TABLE 30: U.S. Internet of Medical Things Market: Medical Sensor and Semiconductor Supply Landscape
TABLE 31: U.S. Internet of Medical Things Market: Connectivity Infrastructure Landscape
TABLE 32: U.S. Internet of Medical Things Market: Cloud and Edge Computing Landscape
TABLE 33: U.S. Internet of Medical Things Market: Healthcare Data Interoperability Landscape
TABLE 34: U.S. Internet of Medical Things Market: AI & Machine Learning Impact Analysis
TABLE 35: U.S. Internet of Medical Things Market: FDA Regulatory Framework Analysis
TABLE 36: U.S. Internet of Medical Things Market: Medical Device Cybersecurity Requirements
TABLE 37: U.S. Internet of Medical Things Market: CMS Remote Patient Monitoring Reimbursement Landscape
TABLE 38: U.S. Internet of Medical Things Market: HIPAA and Healthcare Data Privacy Analysis
TABLE 39: U.S. Internet of Medical Things Market: Government Digital Health Initiatives
TABLE 40: U.S. Internet of Medical Things Market: Hospital Value Analysis Committee Decision Framework
TABLE 41: U.S. Internet of Medical Things Market: Component Snapshot, 2025
TABLE 42: Segment Dashboard; Definition and Scope, by Component
TABLE 43: U.S. Internet of Medical Things Market, by Component, 2021–2035 (US$ Billion)
TABLE 44: U.S. Internet of Medical Things Market: Segment Share Analysis, by Component, 2025 & 2035 (%)
TABLE 45: U.S. Internet of Medical Things Market: Hardware Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. Internet of Medical Things Market: Software & Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Internet of Medical Things Market: Services Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Internet of Medical Things Market: Device Type Snapshot, 2025
TABLE 49: Segment Dashboard; Definition and Scope, by Device Type
TABLE 50: U.S. Internet of Medical Things Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 51: U.S. Internet of Medical Things Market: Segment Share Analysis, by Device Type, 2025 & 2035 (%)
TABLE 52: On-Body and Wearable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: Stationary Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: Implantable Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: Home-Use Connected Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: Portable and Point-of-Care Connected Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Internet of Medical Things Market: Application Snapshot, 2025
TABLE 58: Segment Dashboard; Definition and Scope, by Application
TABLE 59: U.S. Internet of Medical Things Market, by Application, 2021–2035 (US$ Billion)
TABLE 60: U.S. Internet of Medical Things Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 61: Remote Patient Monitoring & Chronic Disease Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: Telemedicine & Virtual Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: Hospital Clinical Workflow & Asset Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: Diagnostics, Imaging & Continuous Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: Medication & Therapy Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Internet of Medical Things Market: End User Snapshot, 2025
TABLE 67: Segment Dashboard; Definition and Scope, by End User
TABLE 68: U.S. Internet of Medical Things Market, by End User, 2021–2035 (US$ Billion)
TABLE 69: U.S. Internet of Medical Things Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 70: Hospitals & Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: Homecare Providers & Patients Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: Physician Practices, Clinics & Ambulatory Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: Diagnostic Centers & Laboratories Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: Pharmaceutical, Research, Payer & Life-Science Organizations Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Internet of Medical Things Market: Regional Snapshot, 2025
TABLE 76: Segment Dashboard; Definition and Scope, by Geography
TABLE 77: U.S. Internet of Medical Things Market, by Region, 2021–2035 (US$ Billion)
TABLE 78: U.S. Internet of Medical Things Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 79: U.S. Internet of Medical Things Market: Regional Connected Device Adoption Analysis
TABLE 80: U.S. Internet of Medical Things Market: Regional Hospital Digital Infrastructure Analysis
TABLE 81: West Region U.S. Internet of Medical Things Market: Regional Overview and Trends
TABLE 82: West Region U.S. Internet of Medical Things Market: Key Manufacturers, Technology Providers and Healthcare Ecosystem
TABLE 83: West Region U.S. Internet of Medical Things Market, by State, 2021–2035 (US$ Billion)
TABLE 84: West Region U.S. Internet of Medical Things Market, by Component, 2021–2035 (US$ Billion)
TABLE 85: West Region U.S. Internet of Medical Things Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 86: West Region U.S. Internet of Medical Things Market, by Application, 2021–2035 (US$ Billion)
TABLE 87: West Region U.S. Internet of Medical Things Market, by End User, 2021–2035 (US$ Billion)
TABLE 88: California Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 89: Washington Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 90: Arizona Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 91: Colorado Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 92: Oregon Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 93: Utah Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 94: Nevada Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 95: New Mexico Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 96: Idaho Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 97: Montana Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 98: Wyoming Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 99: Alaska Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 100: Hawaii Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 101: Northeast Region U.S. Internet of Medical Things Market: Regional Overview and Trends
TABLE 102: Northeast Region U.S. Internet of Medical Things Market: Key Manufacturers, Technology Providers and Healthcare Ecosystem
TABLE 103: Northeast Region U.S. Internet of Medical Things Market, by State, 2021–2035 (US$ Billion)
TABLE 104: Northeast Region U.S. Internet of Medical Things Market, by Component, 2021–2035 (US$ Billion)
TABLE 105: Northeast Region U.S. Internet of Medical Things Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 106: Northeast Region U.S. Internet of Medical Things Market, by Application, 2021–2035 (US$ Billion)
TABLE 107: Northeast Region U.S. Internet of Medical Things Market, by End User, 2021–2035 (US$ Billion)
TABLE 108: New York Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: Massachusetts Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 110: New Jersey Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 111: Pennsylvania Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 112: Connecticut Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 113: Maine Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 114: Vermont Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 115: New Hampshire Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 116: Rhode Island Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 117: Delaware Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 118: South Region U.S. Internet of Medical Things Market: Regional Overview and Trends
TABLE 119: South Region U.S. Internet of Medical Things Market: Key Manufacturers, Technology Providers and Healthcare Ecosystem
TABLE 120: South Region U.S. Internet of Medical Things Market, by State, 2021–2035 (US$ Billion)
TABLE 121: South Region U.S. Internet of Medical Things Market, by Component, 2021–2035 (US$ Billion)
TABLE 122: South Region U.S. Internet of Medical Things Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 123: South Region U.S. Internet of Medical Things Market, by Application, 2021–2035 (US$ Billion)
TABLE 124: South Region U.S. Internet of Medical Things Market, by End User, 2021–2035 (US$ Billion)
TABLE 125: Texas Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: Florida Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: Georgia Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 128: North Carolina Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 129: Tennessee Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: South Carolina Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 131: Alabama Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 132: Mississippi Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 133: Louisiana Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 134: Arkansas Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 135: Kentucky Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 136: Oklahoma Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 137: Virginia Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 138: Maryland Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 139: West Virginia Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: Midwest Region U.S. Internet of Medical Things Market: Regional Overview and Trends
TABLE 141: Midwest Region U.S. Internet of Medical Things Market: Key Manufacturers, Technology Providers and Healthcare Ecosystem
TABLE 142: Midwest Region U.S. Internet of Medical Things Market, by State, 2021–2035 (US$ Billion)
TABLE 143: Midwest Region U.S. Internet of Medical Things Market, by Component, 2021–2035 (US$ Billion)
TABLE 144: Midwest Region U.S. Internet of Medical Things Market, by Device Type, 2021–2035 (US$ Billion)
TABLE 145: Midwest Region U.S. Internet of Medical Things Market, by Application, 2021–2035 (US$ Billion)
TABLE 146: Midwest Region U.S. Internet of Medical Things Market, by End User, 2021–2035 (US$ Billion)
TABLE 147: Illinois Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 148: Ohio Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 149: Michigan Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 150: Minnesota Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 151: Indiana Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 152: Wisconsin Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 153: Missouri Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 154: Iowa Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 155: Kansas Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 156: Nebraska Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 157: North Dakota Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 158: South Dakota Internet of Medical Things Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 159: U.S. Internet of Medical Things Market: Competitive Landscape Snapshot, 2025
TABLE 160: U.S. Internet of Medical Things Market: Key Company Market Share Analysis, 2025
TABLE 161: U.S. Internet of Medical Things Market: Company Positioning Matrix
TABLE 162: U.S. Internet of Medical Things Market: Connected Medical Device Portfolio Benchmarking
TABLE 163: U.S. Internet of Medical Things Market: IoMT Software & Platform Capability Benchmarking
TABLE 164: U.S. Internet of Medical Things Market: AI, Cybersecurity and Interoperability Benchmarking
TABLE 165: U.S. Internet of Medical Things Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 166: Abbott Laboratories: Company Profile
TABLE 167: Medtronic: Company Profile
TABLE 168: GE HealthCare Technologies Inc.: Company Profile
TABLE 169: Koninklijke Philips N.V.: Company Profile
TABLE 170: Siemens Healthineers: Company Profile
TABLE 171: Boston Scientific Corporation: Company Profile
TABLE 172: Johnson & Johnson MedTech: Company Profile
TABLE 173: Baxter International Inc.: Company Profile
TABLE 174: Becton, Dickinson and Company: Company Profile
TABLE 175: Dexcom, Inc.: Company Profile
TABLE 176: Insulet Corporation: Company Profile
TABLE 177: ResMed Inc.: Company Profile
TABLE 178: Masimo Corporation: Company Profile
TABLE 179: iRhythm Technologies, Inc.: Company Profile
TABLE 180: OMRON Healthcare: Company Profile
TABLE 181: F. Hoffmann-La Roche Ltd.: Company Profile
TABLE 182: Stryker Corporation: Company Profile
TABLE 183: Cisco Systems, Inc.: Company Profile
TABLE 184: Microsoft Corporation: Company Profile
TABLE 185: Oracle Corporation: Company Profile
TABLE 186: Honeywell International Inc.: Company Profile
TABLE 187: Zebra Technologies Corporation: Company Profile
TABLE 188: Qualcomm Technologies, Inc.: Company Profile
TABLE 189: BioIntelliSense, Inc.: Company Profile
TABLE 190: AliveCor, Inc.: Company Profile
TABLE 191: U.S. Internet of Medical Things Market: Future Market Scenario Analysis, 2026–2035
TABLE 192: U.S. Internet of Medical Things Market: Disruptive Technologies Impact Matrix
TABLE 193: U.S. Internet of Medical Things Market: Smart Hospital Opportunity Analysis
TABLE 194: U.S. Internet of Medical Things Market: Hospital-at-Home Opportunity Analysis
TABLE 195: U.S. Internet of Medical Things Market: Future Remote Patient Monitoring Reimbursement Outlook
TABLE 196: U.S. Internet of Medical Things Market: Emerging Business Models
TABLE 197: U.S. Internet of Medical Things Market: Business Opportunities for Startups and Existing Players
TABLE 198: U.S. Internet of Medical Things Market: Investment Prioritization Matrix
TABLE 199: U.S. Internet of Medical Things Market: High-Growth Technology Opportunity Matrix
TABLE 200: U.S. Internet of Medical Things Market: High-Growth State Opportunity Matrix
TABLE 201: U.S. Internet of Medical Things Market: Strategic Recommendations for Connected Medical Device Manufacturers
TABLE 202: U.S. Internet of Medical Things Market: Strategic Recommendations for IoMT Software & Platform Providers
TABLE 203: U.S. Internet of Medical Things Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 204: U.S. Internet of Medical Things Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 205: U.S. Internet of Medical Things Market: Go-to-Market Strategy Considerations
TABLE 206: U.S. Internet of Medical Things Market: Cybersecurity and Interoperability Differentiation Strategy
TABLE 207: U.S. Internet of Medical Things Market: Remote Patient Monitoring Commercialization Strategy
TABLE 208: U.S. Internet of Medical Things Market: State-Level Market Entry Prioritization
TABLE 209: U.S. Internet of Medical Things Market: Scope Limitation
TABLE 210: U.S. Internet of Medical Things Market: Data Use and Market Sizing Limitation
TABLE 211: U.S. Internet of Medical Things Market: Forecasting and Technology Adoption Limitation
TABLE 212: U.S. Internet of Medical Things Market: Regulatory and Reimbursement Limitation
TABLE 213: U.S. Internet of Medical Things Market: Legal and Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Internet of Medical Things Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: U.S. Internet of Medical Things Market Ecosystem
FIGURE 4: Stakeholder Ecosystem Analysis
FIGURE 5: U.S. Internet of Medical Things Market Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 6: U.S. Internet of Medical Things Market Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 7: U.S. Internet of Medical Things Market Year-wise Growth Curve, 2021–2035
FIGURE 8: Market Attractiveness Analysis
FIGURE 9: High-Growth Opportunity Map
FIGURE 10: U.S. Internet of Medical Things Market Dynamics
FIGURE 11: Innovation & Patent Landscape, 2021–2025
FIGURE 12: Clinical Workflow Economics Framework
FIGURE 13: Hospital Digital Capital Procurement Decision Framework
FIGURE 14: Connected Device Total Cost of Ownership Framework
FIGURE 15: IoMT Return-on-Investment Framework
FIGURE 16: Remote Monitoring Economics Framework
FIGURE 17: PESTEL Analysis
FIGURE 18: Porter’s Five Forces Analysis
FIGURE 19: Value Chain Analysis
FIGURE 20: Supply Chain Analysis
FIGURE 21: Medical Sensor and Semiconductor Ecosystem
FIGURE 22: IoMT Connectivity Infrastructure Landscape
FIGURE 23: Cloud-to-Edge Healthcare Architecture
FIGURE 24: Medical Device Interoperability Framework
FIGURE 25: AI & Machine Learning Impact Landscape
FIGURE 26: FDA Connected Medical Device Regulatory Framework
FIGURE 27: Medical Device Cybersecurity Lifecycle Framework
FIGURE 28: CMS Remote Patient Monitoring Reimbursement Landscape
FIGURE 29: Hospital IoMT Procurement and Value Analysis Framework
FIGURE 30: Component Segment Market Share Analysis, 2025 & 2035
FIGURE 31: Component Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Hardware Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Software & Platforms Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Services Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Device Type Segment Market Share Analysis, 2025 & 2035
FIGURE 36: Device Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: On-Body and Wearable Medical Devices Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 38: Stationary Connected Medical Devices Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 39: Implantable Connected Medical Devices Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 40: Home-Use Connected Medical Devices Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 41: Portable and Point-of-Care Connected Devices Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 42: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 43: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Remote Patient Monitoring & Chronic Disease Management Market Forecast, 2021–2035
FIGURE 45: Telemedicine & Virtual Care Market Forecast, 2021–2035
FIGURE 46: Hospital Clinical Workflow & Asset Management Market Forecast, 2021–2035
FIGURE 47: Diagnostics, Imaging & Continuous Monitoring Market Forecast, 2021–2035
FIGURE 48: Medication & Therapy Management Market Forecast, 2021–2035
FIGURE 49: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 50: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Hospitals & Integrated Health Systems Market Forecast, 2021–2035
FIGURE 52: Homecare Providers & Patients Market Forecast, 2021–2035
FIGURE 53: Physician Practices, Clinics & Ambulatory Centers Market Forecast, 2021–2035
FIGURE 54: Diagnostic Centers & Laboratories Market Forecast, 2021–2035
FIGURE 55: Pharmaceutical, Research, Payer & Life-Science Organizations Market Forecast, 2021–2035
FIGURE 56: Regional Market Share Analysis, 2025 & 2035
FIGURE 57: Regional Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Regional Connected Medical Device Adoption Index
FIGURE 59: Regional Hospital Digital Infrastructure Readiness Index
FIGURE 60: West Region U.S. Internet of Medical Things Market Share and Leading Players, 2025
FIGURE 61: West Region Market Share Analysis by State, 2025
FIGURE 62: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: California Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 64: Washington Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 65: Arizona Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 66: Colorado Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 67: Oregon Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 68: Utah Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 69: Nevada Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 70: New Mexico Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 71: Idaho Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 72: Montana Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 73: Wyoming Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 74: Alaska Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 75: Hawaii Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 76: Northeast Region U.S. Internet of Medical Things Market Share and Leading Players, 2025
FIGURE 77: Northeast Region Market Share Analysis by State, 2025
FIGURE 78: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: New York Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 80: Massachusetts Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 81: New Jersey Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 82: Pennsylvania Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 83: Connecticut Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 84: Maine Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 85: Vermont Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 86: New Hampshire Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 87: Rhode Island Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 88: Delaware Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 89: South Region U.S. Internet of Medical Things Market Share and Leading Players, 2025
FIGURE 90: South Region Market Share Analysis by State, 2025
FIGURE 91: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Texas Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 93: Florida Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 94: Georgia Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 95: North Carolina Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 96: Tennessee Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 97: South Carolina Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 98: Alabama Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 99: Mississippi Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 100: Louisiana Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 101: Arkansas Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 102: Kentucky Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 103: Oklahoma Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 104: Virginia Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 105: Maryland Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 106: West Virginia Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 107: Midwest Region U.S. Internet of Medical Things Market Share and Leading Players, 2025
FIGURE 108: Midwest Region Market Share Analysis by State, 2025
FIGURE 109: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Illinois Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 111: Ohio Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 112: Michigan Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 113: Minnesota Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 114: Indiana Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 115: Wisconsin Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 116: Missouri Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 117: Iowa Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 118: Kansas Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 119: Nebraska Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 120: North Dakota Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 121: South Dakota Internet of Medical Things Market Size and Trend Analysis, 2021–2035
FIGURE 122: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 123: Company Positioning Matrix
FIGURE 124: Connected Medical Device Portfolio Benchmarking
FIGURE 125: IoMT Software & Platform Capability Benchmarking
FIGURE 126: AI, Cybersecurity and Interoperability Competitive Benchmarking
FIGURE 127: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 128: U.S. IoMT Innovation Roadmap
FIGURE 129: AI-Enabled Connected Medical Device Adoption Roadmap
FIGURE 130: Remote Patient Monitoring Growth Roadmap
FIGURE 131: Smart Hospital IoMT Opportunity Map
FIGURE 132: Hospital-at-Home IoMT Adoption Roadmap
FIGURE 133: Medical Device Cybersecurity Evolution Roadmap
FIGURE 134: Cloud-to-Edge IoMT Architecture Evolution
FIGURE 135: Future Market Scenario Analysis, 2026–2035
FIGURE 136: Disruptive Technologies Impact Matrix
FIGURE 137: Emerging IoMT Business Models Matrix
FIGURE 138: Investment Prioritization Matrix
FIGURE 139: High-Growth Technology Opportunity Matrix
FIGURE 140: High-Growth State Opportunity Map
FIGURE 141: Strategic Growth Roadmap for Connected Medical Device Manufacturers
FIGURE 142: Strategic Growth Roadmap for IoMT Software & Platform Providers
FIGURE 143: Hospital IoMT Commercialization Framework
FIGURE 144: Go-to-Market Strategy Framework
FIGURE 145: Cybersecurity and Interoperability Differentiation Framework
FIGURE 146: Remote Patient Monitoring Commercialization Framework
FIGURE 147: State-Level Market Entry Prioritization Framework
FIGURE 148: Report Scope and Disclaimer Framework